Want to join the conversation?
Joshua Jennings of Cowen & Co. asks about biosimilar competition to the REMICADE franchise in 2017 and beyond. $JNJ CFO Dominic Caruso said the company does not expect biosimilar competition in 2016. $JNJ has several patents that it intends to defend. Overall, the immunology franchise is very strong and remain comfortable with the growth outlook.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.